e-learning
resources
Virtual 2020
Pre-Congress Content
Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis
J. Kang (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea)
Source:
Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session:
Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session type:
E-poster session
Number:
800
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kang (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea). Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis. 800
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018
Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis
Source: Eur Respir J, 51 (6) 1800430; 10.1183/13993003.00430-2018
Year: 2018
Pulmonary hemodynamics and mortality in chronic hypersensitivity pneumonitis
Source: International Congress 2017 – Rare diseases
Year: 2017
Factors associated with increased arterial stiffness in patients with chronic hypersensitivity pneumonitis
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Anemia predicts mortality after COPD exacerbation
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Small airways impairment and air-trapping in patients with chronic hypersensitivity pneumonitis (CHP) of different severity
Source: International Congress 2017 – Novel and old entities
Year: 2017
Emphysematous changes in chronic hypersensitivity pneumonitis: A retrospective analysis of 12 patients
Source: International Congress 2016 – Orphan diseases II
Year: 2016
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
APACHE II and MPMo scores in prediction of outcomes in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 83s
Year: 2002
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept